Immix Biopharma, Inc. (IMMX)
9.29
-0.20
(-2.11%)
USD |
NASDAQ |
Oct 08, 16:00
9.27
-0.02
(-0.22%)
After-Hours: 06:57
Immix Biopharma Price : 9.29 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 9.34 | 9.37 | 8.96 | 9.29 | 1.289M |
| Oct 07, 2026 | 9.50 | 9.69 | 9.40 | 9.49 | 1.382M |
| Oct 06, 2026 | 10.20 | 10.20 | 9.515 | 9.64 | 1.215M |
| Oct 05, 2026 | 9.71 | 10.33 | 9.55 | 10.13 | 1.598M |
| Oct 02, 2026 | 10.35 | 10.37 | 9.48 | 9.68 | 2.548M |
| Oct 01, 2026 | 10.25 | 10.48 | 9.86 | 10.23 | 1.648M |
| Sep 30, 2026 | 10.61 | 11.25 | 10.39 | 10.40 | 2.409M |
| Sep 29, 2026 | 11.64 | 11.85 | 10.07 | 10.54 | 5.760M |
| Sep 28, 2026 | 10.82 | 11.84 | 10.70 | 11.47 | 995932.0 |
| Sep 25, 2026 | 11.78 | 11.99 | 10.82 | 10.97 | 1.828M |
| Sep 24, 2026 | 11.87 | 11.97 | 11.18 | 11.70 | 1.536M |
| Sep 23, 2026 | 12.80 | 12.84 | 11.71 | 11.92 | 1.168M |
| Sep 22, 2026 | 12.45 | 12.90 | 12.31 | 12.83 | 948505.0 |
| Sep 21, 2026 | 12.59 | 12.71 | 12.14 | 12.47 | 1.330M |
| Sep 18, 2026 | 12.68 | 12.84 | 12.34 | 12.50 | 4.184M |
| Sep 17, 2026 | 12.24 | 12.75 | 12.07 | 12.72 | 1.186M |
| Sep 16, 2026 | 12.28 | 12.46 | 11.75 | 11.92 | 1.422M |
| Sep 15, 2026 | 12.49 | 12.63 | 11.81 | 12.14 | 1.055M |
| Sep 14, 2026 | 12.44 | 12.59 | 11.98 | 12.21 | 1.080M |
| Sep 11, 2026 | 12.86 | 13.29 | 12.02 | 12.14 | 1.191M |
| Sep 10, 2026 | 12.08 | 12.77 | 11.91 | 12.70 | 1.656M |
| Sep 09, 2026 | 13.12 | 13.23 | 12.24 | 12.31 | 1.286M |
| Sep 08, 2026 | 13.70 | 13.89 | 12.75 | 13.25 | 1.420M |
| Sep 04, 2026 | 13.68 | 14.08 | 13.60 | 13.91 | 1.051M |
| Sep 03, 2026 | 14.14 | 14.14 | 13.52 | 13.83 | 987216.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Atossa Therapeutics, Inc. | 2.42 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |
| Savara, Inc. | 4.83 |
| Vericel Corp. | 40.05 |
Price Related Metrics
| PEG Ratio | -0.9418 |
| Price to Book Value | 2.903 |
| Earnings Yield | -9.47% |
| Market Cap | 664.57M |
| PEGY Ratio | -0.9418 |